Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Neuromonitoring Devices Market, by Product
1.4.2 Europe Neuromonitoring Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Neuromonitoring Device Market
Chapter 4. Europe Neuromonitoring Devices Market by Product
4.1 Europe Doppler Ultrasound Market by Country
4.2 Europe EEG Market by Country
4.3 Europe Fetal/Neonatal Neuro-Monitoring Devices Market by Country
4.4 Europe Intracranial Pressure Monitoring Market by Country
4.5 Europe Cerebral Oximeter Market by Country
4.6 Europe Near Infrared Spectroscopy Market by Country
4.7 Europe Speckle Imaging Market by Country
4.8 Europe Micro Ultrasound Market by Country
4.9 Europe Others Market by Country
Chapter 5. Europe Neuromonitoring Devices Market by Country
5.1 Germany Neuromonitoring Devices Market
5.1.1 Germany Neuromonitoring Devices Market by Product
5.2 UK Neuromonitoring Devices Market
5.2.1 UK Neuromonitoring Devices Market by Product
5.3 France Neuromonitoring Devices Market
5.3.1 France Neuromonitoring Devices Market by Product
5.4 Russia Neuromonitoring Devices Market
5.4.1 Russia Neuromonitoring Devices Market by Product
5.5 Spain Neuromonitoring Devices Market
5.5.1 Spain Neuromonitoring Devices Market by Product
5.6 Italy Neuromonitoring Devices Market
5.6.1 Italy Neuromonitoring Devices Market by Product
5.7 Rest of Europe Neuromonitoring Devices Market
5.7.1 Rest of Europe Neuromonitoring Devices Market by Product
Chapter 6. Company Profiles
6.1 Medtronic PLC
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Approvals and Trials:
6.1.5.2 Acquisition and Mergers:
6.2 NuVasive, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Approvals and Trials:
6.3 General Electric (GE) Co. (GE Healthcare)
6.3.1 Company Overview
6.3.2 Segmental and Regional Analysis
6.3.3 Research & Development Expense
6.3.4 Recent strategies and developments:
6.3.4.1 Partnerships, Collaborations, and Agreements:
6.3.5 SWOT Analysis
6.4 Natus Medical Incorporated
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional & Segmental Analysis
6.4.4 Research & Development Expenses
6.5 Koninklijke Philips N.V.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Acquisition and Mergers:
6.6 SpecialtyCare
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Acquisition and Mergers:
6.7 Nihon Kohden Corporation
6.7.1 Company Overview
6.8 Advanced Brain Monitoring, Inc.
6.8.1 Company Overview
6.9 IntraNerve Neuroscience Holdings, LLC
6.9.1 Company Overview
6.10. Rimed Ltd.
6.10.1 Company Overview
Unique Offerings 